PIH1D3 Inhibitors
The functional inhibition of PIH1D3 is complex and involves a multitude of cellular signaling pathways that can be influenced by various chemical inhibitors. Compounds that target the phosphoinositide 3-kinase (PI3K) pathway can lead to downstream effects that diminish the activity of PIH1D3, due to its potential role in signaling cascades that rely on PI3K. Similarly, given the possible involvement of PIH1D3 in mTOR-controlled protein synthesis, mTOR inhibitors are capable of indirectly reducing PIH1D3 activity by impairing the translational machinery. Furthermore, protein kinase inhibitors, specifically those that target MEK, p38 MAPK, and JNK, can impede pathways that may be crucial for PIH1D3's role in cellular stress responses or apoptosis, thereby indirectly reducing its activity. Inhibition of protein kinase C also contributes to the attenuation of PIH1D3 activity by potentially altering signaling events that regulate its function.
Additional chemical compounds that inhibit key cellular processes can affect PIH1D3's activity indirectly. For example, proteasome inhibitors disrupt proteostasis, leading to aberrant protein accumulation that could impede PIH1D3's interactions and functionality. Hsp90 inhibitors, by destabilizing client proteins that may interact with or regulate PIH1D3, can also contribute to a decrease in its functional activity. Aurora kinase inhibitors, by obstructing cell cycle-related pathways, may similarly impact PIH1D3 if it is associated with these processes.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
As a potent inhibitor of phosphoinositide 3-kinases (PI3K), this compound indirectly affects PIH1D3 by disrupting PI3K-related signaling pathways that are critical for certain cellular processes, leading to a decrease in PIH1D3-associated cellular activities. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
This compound is a synthetic molecule that inhibits PI3K, which indirectly causes a reduction in PIH1D3 activity by attenuating the PI3K/AKT signaling pathway, a pathway that PIH1D3 may be involved in. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
As an mTOR inhibitor, this compound can disrupt the mTOR signaling pathway. Given PIH1D3's potential involvement in protein translation processes regulated by mTOR, its functional activity could be indirectly inhibited by this compound. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
This alkaloid acts as a potent inhibitor of protein kinases. By inhibiting kinases that may interact with PIH1D3 or modulate its function, it can lead to a decrease in PIH1D3's functional activity. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
This compound is a selective inhibitor of MEK, which operates in the MAPK/ERK pathway. By dampening this pathway, it may indirectly decrease PIH1D3 activity if PIH1D3 is involved in MAPK/ERK signaling. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
As an inhibitor of p38 MAPK, this compound indirectly affects PIH1D3 by blocking the p38 MAPK signaling cascade, which can influence PIH1D3's role in stress responses or other related cellular processes. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
This is an inhibitor of JNK, and by blocking JNK signaling, this compound can indirectly inhibit PIH1D3 if PIH1D3 is implicated in the JNK pathway, affecting stress responses and apoptosis. | ||||||
Gö 6983 | 133053-19-7 | sc-203432 sc-203432A sc-203432B | 1 mg 5 mg 10 mg | $105.00 $299.00 $474.00 | 15 | |
This potent protein kinase C inhibitor can decrease PIH1D3 activity by obstructing the PKC pathway, which may be necessary for the proper function or regulation of PIH1D3. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
As an inhibitor of MEK1/2, this compound can lead to decreased PIH1D3 activity by interfering with the MEK/ERK pathway, which PIH1D3 may be a part of, thereby affecting cell proliferation and differentiation processes. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
This proteasome inhibitor can lead to the accumulation of misfolded proteins, indirectly affecting PIH1D3 by disrupting proteostasis and potentially impacting PIH1D3's functional interactions within the cell. | ||||||